Heranba Q3 FY26: Standalone PAT at Rs 9.32 cr, 9M revenue up 27% YoY

Net loss reportedResults View source PDF Explain this filing

HERANBA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-7.2%Reaction day

₹229.50

prior close

₹220.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-6.7% vs market

Pesticides & Agrochemicals peers, median of 26sector-0.3%-7.0% vs sector

On the reaction day the stock moved 6.7 pts less than Nifty Microcap 250 and 7.0 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.8

10m

-1.9

15m

-1.9

30m

-2.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-7.2-0.5-6.7-0.3-7.0

Next day

-9.8-2.0-7.8-1.5-8.3

-9.1-2.7-6.4-3.1-6.0

-8.5-1.7-6.8-2.6-5.9

-5.1-1.4-3.6-2.7-2.4

-7.5-2.8-4.7-3.0-4.6

-9.4-2.8-6.5-5.1-4.3

15d

-15.0-8.4-6.6-9.3-5.7

-20.0-9.1-10.9-9.7-10.3

-12.8-4.0-8.8-8.3-4.5

-8.5+2.6-11.2-4.3-4.3

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Heranba Industries posted Q3 FY26 standalone revenue of Rs 306.55 cr (down about 9% YoY) with PAT of Rs 9.32 cr versus a loss of Rs 9.12 cr last year. For 9M FY26, standalone revenue grew 27% to Rs 1,402 cr with PAT at Rs 63.38 cr. Consolidated Q3 showed a loss of Rs 23.29 cr (worsened from Rs 0.37 cr loss). Auditor NVC and Associates gave an unmodified limited review. Board also appointed ZMAS and Associates as new internal auditor from Jan 2026 to Mar 2027.

Likely market impact

Mixed bag: strong standalone 9M growth and Q3 turnaround, but consolidated losses widened sharply, raising concern over subsidiary performance.